• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人源化鼠嵌合抗体对系统性硬化症具有高亲和力和特异性。

Human-murine chimeric autoantibodies with high affinity and specificity for systemic sclerosis.

机构信息

Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou, China.

Department of Pharmacy, Fujian Provincial Hospital, Fuzhou, China.

出版信息

Front Immunol. 2023 Jun 16;14:1127849. doi: 10.3389/fimmu.2023.1127849. eCollection 2023.

DOI:10.3389/fimmu.2023.1127849
PMID:37398644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10311643/
Abstract

Scleroderma 70 (Scl-70) is commonly used in the clinic for aiding systemic sclerosis (SSc) diagnosis due to its recognition as autoantibodies in the serum of SSc patients. However, obtaining sera positive for anti-Scl-70 antibody can be challenging; therefore, there is an urgent need to develop a specific, sensitive, and easily available reference for SSc diagnosis. In this study, murine-sourced scFv library were screened by phage display technology against human Scl-70, and the scFvs with high affinity were constructed into humanized antibodies for clinical application. Finally, ten high-affinity scFv fragments were obtained. Three fragments (2A, 2AB, and 2HD) were select for humanization. The physicochemical properties of the amino acid sequence, three-dimensional structural basis, and electrostatic potential distribution of the protein surface of different scFv fragments revealed differences in the electrostatic potential of their CDR regions determined their affinity for Scl-70 and expression. Notably, the specificity test showed the half-maximal effective concentration values of the three humanized antibodies were lower than that of positive patient serum. Moreover, these humanized antibodies showed high specificity for Scl-70 in diagnostic immunoassays for ANA. Among these three antibodies, 2A exhibited most positive electrostatic potential on the surface of the CDRs and highest affinity and specificity for Scl-70 but with least expression level; thus, it may provide new foundations for developing enhanced diagnostic strategies for SSc.

摘要

硬皮病 70(Scl-70)通常在临床上用于辅助系统性硬皮病(SSc)的诊断,因为它被认为是 SSc 患者血清中的自身抗体。然而,获得抗 Scl-70 抗体阳性的血清可能具有挑战性;因此,迫切需要开发一种特异性、敏感性和易于获得的 SSc 诊断参考物。在这项研究中,通过噬菌体展示技术筛选了针对人 Scl-70 的鼠源 scFv 文库,并将高亲和力的 scFv 构建成可用于临床应用的人源化抗体。最终获得了十个高亲和力的 scFv 片段。选择三个片段(2A、2AB 和 2HD)进行人源化。不同 scFv 片段的氨基酸序列理化性质、三维结构基础和蛋白质表面的静电势分布揭示了其 CDR 区域静电势的差异,决定了它们与 Scl-70 的亲和力和表达。值得注意的是,特异性测试表明,三种人源化抗体的半数有效浓度值均低于阳性患者血清。此外,这些人源化抗体在 ANA 的诊断免疫测定中对 Scl-70 具有高度特异性。在这三种抗体中,2A 在 CDR 表面表现出最强的正静电势和对 Scl-70 的最高亲和力和特异性,但表达水平最低;因此,它可能为开发增强的 SSc 诊断策略提供新的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12b/10311643/66da6f3d4222/fimmu-14-1127849-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12b/10311643/8f342c3bd2fb/fimmu-14-1127849-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12b/10311643/9a3395514f56/fimmu-14-1127849-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12b/10311643/a284ac24c3bc/fimmu-14-1127849-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12b/10311643/ed35490fce2e/fimmu-14-1127849-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12b/10311643/bebb4e423a1c/fimmu-14-1127849-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12b/10311643/66da6f3d4222/fimmu-14-1127849-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12b/10311643/8f342c3bd2fb/fimmu-14-1127849-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12b/10311643/9a3395514f56/fimmu-14-1127849-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12b/10311643/a284ac24c3bc/fimmu-14-1127849-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12b/10311643/ed35490fce2e/fimmu-14-1127849-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12b/10311643/bebb4e423a1c/fimmu-14-1127849-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c12b/10311643/66da6f3d4222/fimmu-14-1127849-g006.jpg

相似文献

1
Human-murine chimeric autoantibodies with high affinity and specificity for systemic sclerosis.人源化鼠嵌合抗体对系统性硬化症具有高亲和力和特异性。
Front Immunol. 2023 Jun 16;14:1127849. doi: 10.3389/fimmu.2023.1127849. eCollection 2023.
2
Combining EL4-B5-based B-cell stimulation and phage display technology for the successful isolation of human anti-Scl-70 autoantibody fragments.结合基于EL4-B5的B细胞刺激和噬菌体展示技术成功分离人抗Scl-70自身抗体片段。
J Immunol Methods. 2003 Jul;278(1-2):249-59. doi: 10.1016/s0022-1759(03)00228-x.
3
False positive anti-Topoisomerase I (Scl-70) antibody results in clinical practice: A case series from a scleroderma referral center.临床实践中抗拓扑异构酶I(Scl-70)抗体假阳性结果:来自硬皮病转诊中心的病例系列
Semin Arthritis Rheum. 2022 Oct;56:152052. doi: 10.1016/j.semarthrit.2022.152052. Epub 2022 Jun 17.
4
Evaluation of a commercial immunoassay for autoantibodies in Chinese Han systemic sclerosis population.评估商业免疫测定法在中国汉族系统性硬化症人群中的自身抗体。
Clin Chim Acta. 2019 Apr;491:121-125. doi: 10.1016/j.cca.2019.01.020. Epub 2019 Jan 24.
5
Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients.抗PM/Scl-75和PM/Scl-100抗体是系统性硬化症患者不同亚组的独立标志物。
Arthritis Res Ther. 2009;11(1):R22. doi: 10.1186/ar2614. Epub 2009 Feb 16.
6
Mapping of epitopes recognized by PM/Scl autoantibodies with gene-fragment phage display libraries.利用基因片段噬菌体展示文库对PM/Scl自身抗体识别的表位进行定位
J Immunol Methods. 1996 Nov 13;198(2):187-98. doi: 10.1016/s0022-1759(96)00160-3.
7
Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.德国系统性硬皮病网络患者中与疾病相关的核自身抗体和其他核自身抗体的频率:与特征性临床特征的相关性。
Arthritis Res Ther. 2011;13(5):R172. doi: 10.1186/ar3495. Epub 2011 Oct 21.
8
Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies.系统性硬化症的检测表现:抗着丝点抗体和抗Scl-70抗体
Am J Med. 1997 Sep;103(3):242-8. doi: 10.1016/s0002-9343(97)00023-5.
9
Anti-PM-Scl antibody in patients with systemic sclerosis.抗 PM-Scl 抗体在系统性硬化症患者中的应用。
Clin Exp Rheumatol. 2012 Mar-Apr;30(2 Suppl 71):S12-6. Epub 2012 May 29.
10
Anti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.除了肌炎和硬皮病之外,在患有各种系统性自身免疫性疾病的日本患者中发现了抗PM/Scl抗体。
Arthritis Res Ther. 2015 Mar 11;17(1):57. doi: 10.1186/s13075-015-0573-x.

本文引用的文献

1
Advances in antibody phage display technology.抗体噬菌体展示技术的进展。
Drug Discov Today. 2022 Aug;27(8):2151-2169. doi: 10.1016/j.drudis.2022.05.002. Epub 2022 May 10.
2
An overview on display systems (phage, bacterial, and yeast display) for production of anticancer antibodies; advantages and disadvantages.展示系统(噬菌体、细菌和酵母展示)在生产抗癌抗体方面的概述;优缺点。
Int J Biol Macromol. 2022 May 31;208:421-442. doi: 10.1016/j.ijbiomac.2022.03.113. Epub 2022 Mar 24.
3
Advances in the Development of Phage-Based Probes for Detection of Bio-Species.
噬菌体探针检测生物种属的研究进展。
Biosensors (Basel). 2022 Jan 7;12(1):30. doi: 10.3390/bios12010030.
4
Autoantibodies in the disease criteria for systemic sclerosis: The need for specification for optimal application.系统性硬化症疾病标准中的自身抗体:优化应用所需的规范
J Transl Autoimmun. 2022 Jan 4;5:100141. doi: 10.1016/j.jtauto.2022.100141. eCollection 2022.
5
Combining random mutagenesis, structure-guided design and next-generation sequencing to mitigate polyreactivity of an anti-IL-21R antibody.结合随机诱变、结构导向设计和下一代测序来减轻抗 IL-21R 抗体的多反应性。
MAbs. 2021 Jan-Dec;13(1):1883239. doi: 10.1080/19420862.2021.1883239.
6
The Clustal Omega Multiple Alignment Package.Clustal Omega多序列比对软件包。
Methods Mol Biol. 2021;2231:3-16. doi: 10.1007/978-1-0716-1036-7_1.
7
Magnetic bead-based semi-automated phage display panning strategy for the directed evolution of antibodies.基于磁珠的半自动噬菌体展示淘选策略用于抗体的定向进化
Methods Enzymol. 2020;630:159-178. doi: 10.1016/bs.mie.2019.10.023. Epub 2019 Oct 31.
8
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.系统性硬化症伴间质性肺病的病因、危险因素和生物标志物。
Am J Respir Crit Care Med. 2020 Mar 15;201(6):650-660. doi: 10.1164/rccm.201903-0563CI.
9
IMGT and 30 Years of Immunoinformatics Insight in Antibody V and C Domain Structure and Function.国际免疫基因组数据库(IMGT)与抗体V区和C区结构及功能的免疫信息学30年洞察
Antibodies (Basel). 2019 Apr 11;8(2):29. doi: 10.3390/antib8020029.
10
Interactions of HLA-DR and Topoisomerase I Epitope Modulated Genetic Risk for Systemic Sclerosis.HLA-DR 和拓扑异构酶 I 表位相互作用调节系统性硬化症的遗传风险。
Sci Rep. 2019 Jan 24;9(1):745. doi: 10.1038/s41598-018-37038-z.